TrialCancer medicine2015

Induction therapy with cetuximab plus docetaxel, cisplatin, and 5-fluorouracil (ETPF) in patients with resectable nonmetastatic stage III or IV squamous cell carcinoma of the oropharynx. A GERCOR phase II ECHO-07 study.

Benoist Chibaudel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.